Patents
Sitemap › C40 - Combinatorial technology › C40B - Combinatorial chemistry; Libraries, e.g. chemical libraries, in silico libraries › C40B 30 - Methods of screening libraries
Patents for C40B 30 - Methods of screening libraries (11,320)
02/2012
02/23/2012US20120046195 Detecting bcl-b expression in cancer and uses thereof
02/23/2012US20120046194 METHOD FOR DIAGNOSING ACUTE LYMPHOMIC LEUKEMIA (ALL) USING MIR-146a
02/23/2012US20120046193 Method for diagnosing acute lymphomic leukemia (all) using mir-222
02/23/2012US20120046192 Method for diagnosing acute lymphomic leukemia (all) using mir-221
02/23/2012US20120046191 Automated detection and counting of biomolecules using nanoparticle probes
02/23/2012US20120046190 Hp1alpha as a prognostic marker in human cancer
02/23/2012US20120046189 Markers related to age-related macular degeneration and uses therefor
02/23/2012US20120046188 Solid Support for HCV Detection
02/23/2012US20120046187 Analysis chip, analysis method and method for stirring solution
02/23/2012US20120046186 Gene Expression Markers for Prediction of Response to Platinum-Based Chemotherapy Drugs
02/23/2012US20120046185 Panel of biomarkers for ovarian cancer
02/23/2012US20120046184 method for the selective concentration of a specific low abundance biomolecule
02/23/2012US20120046183 method of diagnosing a mental state
02/23/2012US20120046182 Neoepitope detection of disease using protein arrays
02/23/2012US20120046181 Biomarkers for the Diagnosis of Renal Allograft and Kidney Status
02/23/2012US20120046180 Releasable nonvolatile mass-label molecules
02/23/2012US20120046179 Method of pooling samples for performing a biological assay
02/23/2012US20120045766 Jarid1b for target gene of cancer therapy and diagnosis
02/23/2012US20120045474 Substrate peptide sequences for plague plasminogen activator and uses thereof
02/23/2012US20120045439 Tumor markers and methods of use thereof
02/23/2012US20120045395 MicroRNAs In Idiopathic Pulmonary Fibrosis
02/23/2012US20120045394 Human and mouse targeting peptides identified by phage display
02/23/2012CA2808859A1 Cancer diagnostic and cancer therapeutic
02/23/2012CA2808417A1 Circulating biomarkers for disease
02/23/2012CA2807209A1 Markers of the male urogenital tract
02/23/2012CA2716302A1 Compositions and methods for determining likelihood of an increased susceptibility to contract johne's disease
02/22/2012EP2420516A1 Rapid generation of T cell-independent antibody responses to T cell-dependent antigens
02/22/2012EP2419534A1 Signature of secreted protein isoforms specific to ovarian cancer
02/22/2012EP2419533A1 Process for tumour characteristic and marker set identification, tumour classification and marker sets for cancer
02/21/2012US8119572 Methods for determining protein binding specificity using peptide libraries
02/16/2012WO2012021795A2 Pancreatic cancer biomarkers and uses thereof
02/16/2012WO2012021647A2 Modulators of nod1 and nod2 signaling, methods of identifying modulators of nod1 and nod2 signaling, and uses thereof
02/16/2012WO2012019300A1 Endometrial cancer biomarkers and methods of identifying and using same
02/16/2012US20120042407 Corn event 5307
02/16/2012US20120042398 Compositions for labeling and identifying autophagosomes and methods for making and using them
02/16/2012US20120041274 Cancer biomarkers
02/16/2012US20120041017 Pyridocarbazole type compounds and applications thereof
02/16/2012US20120040938 Glucocorticoid receptor alleles and uses thereof
02/16/2012US20120040906 Protein targets in disease
02/16/2012US20120040866 High Resolution Label Free Analysis of Cellular Properties
02/16/2012US20120040865 Target substance detection method using aptamer
02/16/2012US20120040864 Method for Determining the Cbl-b Expression
02/16/2012US20120040863 Process for tumour characteristic and marker set identification, tumour classification and marker sets for cancer
02/16/2012US20120040862 Method for detecting and quantifying endogenous wheat dna sequence
02/16/2012US20120040861 Pancreatic Cancer Biomarkers and Uses Thereof
02/16/2012US20120040860 Methods for Determining Protein Binding Specificity Using Peptide Libraries
02/16/2012US20120040859 Assay systems for genetic analysis
02/16/2012US20120040858 Biomarkers for stroke
02/16/2012US20120040857 Isolation of factors that associate directly or indirectly with chromatin
02/16/2012US20120040856 Method for detecting the presence of liquids in a microfluidic device, detecting apparatus and corresponding microfluidic device
02/16/2012US20120040855 Tissue-specific aging biomarkers
02/16/2012US20120040854 Method for in vitro diagnosis or prognosis of testicular cancer
02/16/2012US20120040853 Real time multiplex pcr detection on solid surfaces using double stranded nucleic acid specific dyes
02/16/2012US20120040852 Biomarkers
02/16/2012US20120040851 miRNA TARGETS
02/16/2012US20120040850 Methods for Diagnosis and Assessment of Autoimmune Disorders
02/16/2012US20120040849 Gene expression profile as an endometrial receptivity marker
02/16/2012US20120040848 Molecular signature of liver tumor grade and use to evaluate prognosis and therapeutic regimen
02/16/2012US20120040847 Personal Diabetic Carbohydrate Counting Procedure System and Method
02/16/2012US20120040846 Methods of Detecting Diseases or Conditions Using Phagocytic Cells
02/16/2012US20120040845 Advanced pathogen testing and carcass-certification methods for slaughter operations
02/16/2012US20120040844 Methods and Apparatus for Measuring Analytes Using Large Scale FET Arrays
02/16/2012US20120040843 Centrifugal capture system
02/16/2012US20120040842 Gene Expression Markers for Prediction of Patient Response to Chemotherapy
02/16/2012US20120040457 Small molecules that replace or agonize p53 function
02/16/2012US20120040021 Methods and compositions for the treatment of cancer
02/16/2012US20120039902 Method for the treatment of t cell mediated conditions by depletion of icos-positive cells in vivo
02/16/2012US20120039900 Biomarkers predictive of the responsiveness to tnfalpha inhibitors in autoimmune disorders
02/16/2012US20120039889 Methods of diagnosing and treating prostate cancer characterized by ndrg1-erg fusion
02/16/2012US20120039868 Biomarkers for Graft Rejection
02/16/2012US20120039812 Genes associated with posttraumatic-stress disorder (ptsd)
02/16/2012US20120039811 Markers for cancer detection
02/16/2012US20120039808 Brain Tumor Stem Cell Differentiation Promoter, and Therapeutic Agent for Brain Tumor
02/16/2012US20120039805 Therapeutics And Methods For Treating Neoplastic Diseases Comprising Determining The Level Of Caveolin-1 And/Or Caveolin-2 In A Stromal Cell Sample
02/16/2012CA2804857A1 Pancreatic cancer biomarkers and uses thereof
02/15/2012EP2417269A1 Genetic marker identification in atlantic cod
02/09/2012WO2012018387A2 Compositions and methods for discovery of causative mutations in genetic disorders
02/09/2012WO2011150221A3 Compounds and methods of modulating mitochondrial bioenergetic efficiency through an interaction with atp synthase (complex v) and its subunits
02/09/2012US20120036597 Cold-Tolerant Plants
02/09/2012US20120035245 Methods for identifying and compounds useful for the diagnosis and treatment of diseases involving inflammation
02/09/2012US20120035242 Pharmaceutical composition for treating obesity or diabetes
02/09/2012US20120035126 Compounds For Reducing Drug Resistance And Uses Thereof
02/09/2012US20120035080 Optical lens system and method for microfluidic devices
02/09/2012US20120035079 Genotoxicity testing
02/09/2012US20120035078 Engineering complex microbial phenotypes with transcription enhancement
02/09/2012US20120035077 Modified renilla luciferase nucleic acids and methods of use
02/09/2012US20120035076 Irak kinase family as novel target and biomarker for alzheimer
02/09/2012US20120035075 Cartridge for an amplification process
02/09/2012US20120035074 Methods to determine atherosclerosis regression, plaque stabiliztion and cardiovascular risk
02/09/2012US20120035073 Compositions and methods for the treatment of immune related diseases
02/09/2012US20120035072 Kaspp (lrrk2) gene, its production and use for the detection and treatment of neurodegenerative disorders
02/09/2012US20120035071 Highly conserved genes and their use to generate probes and primers for detection of microorganisms
02/09/2012US20120035070 Coelenterazine analogs and manufacturing method thereof
02/09/2012US20120035069 Prognosis of breast cancer patients by monitoring the expression of two genes
02/09/2012US20120035068 Use of mirco-rna as a biomarker of immunomodulatory drug activity
02/09/2012US20120035067 Marker Panels For Idiopathic Pulmonary Fibrosis Diagnosis And Evaluation
02/09/2012US20120035066 Conjugated polymers for use in homogeneous and solid state assays
02/09/2012US20120035065 Aptamer Regulated Nucleic Acids and Uses Thereof
02/09/2012US20120035064 Polymorph, polymorph screening system, and polymorph preparing and screening method
02/09/2012US20120035063 Use of Chemically Patterned Substrate for Liquid Handling, Chemical and Biological Reactions
1 ... 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 ... 114